Literature DB >> 19888800

Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.

Sónia Silva1, Mariana Henriques, António Martins, Rosário Oliveira, David Williams, Joana Azeredo.   

Abstract

Most cases of candidiasis have been attributed to C. albicans, but recently, non- Candida albicans Candida (NCAC) species have been identified as common pathogens. The ability of Candida species to form biofilms has important clinical repercussions due to their increased resistance to antifungal therapy and the ability of yeast cells within the biofilms to withstand host immune defenses. Given this clinical importance of the biofilm growth form, the aim of this study was to characterize biofilms produced by three NCAC species, namely C. parapsilosis, C. tropicalis and C. glabrata. The biofilm forming ability of clinical isolates of C. parapsilosis, C. tropicalis and C. glabrata recovered from different sources, was evaluated by crystal violet staining. The structure and morphological characteristics of the biofilms were also assessed by scanning electron microscopy and the biofilm matrix composition analyzed for protein and carbohydrate content. All NCAC species were able to form biofilms although these were less extensive for C. glabrata compared with C. parapsilosis and C. tropicalis. It was evident that C. parapsilosis biofilm production was highly strain dependent, a feature not evident with C. glabrata and C. tropicalis. Scanning electron microscopy revealed structural differences for biofilms with respect to cell morphology and spatial arrangement. Candida parapsilosis biofilm matrices had large amounts of carbohydrate with less protein. Conversely, matrices extracted from C. tropicalis biofilms had low amounts of carbohydrate and protein. Interestingly, C. glabrata biofilm matrix was high in both protein and carbohydrate content. The present work demonstrates that biofilm forming ability, structure and matrix composition are highly species dependent with additional strain variability occurring with C. parapsilosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888800     DOI: 10.3109/13693780802549594

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  115 in total

1.  The Activities of Adhesion and Biofilm Formation by Candida tropicalis Clinical Isolates Display Significant Correlation with Its Multilocus Sequence Typing.

Authors:  Shuan Bao Yu; Wen Ge Li; Xiao Shu Liu; Jie Che; Jin Xing Lu; Yuan Wu
Journal:  Mycopathologia       Date:  2017-01-13       Impact factor: 2.574

2.  Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H, 31H-phthalocyanine (ZnPc).

Authors:  J C Junqueira; A O C Jorge; J O Barbosa; R D Rossoni; S F G Vilela; A C B P Costa; F L Primo; J M Gonçalves; A C Tedesco; J M A H Suleiman
Journal:  Lasers Med Sci       Date:  2012-01-26       Impact factor: 3.161

3.  Susceptibility of multispecies biofilm to photodynamic therapy using Photodithazine®.

Authors:  Cristiane Campos Costa Quishida; Juliana Cabrini Carmello; Ewerton Garcia de Oliveira Mima; Vanderlei Salvador Bagnato; Ana Lúcia Machado; Ana Cláudia Pavarina
Journal:  Lasers Med Sci       Date:  2013-08-03       Impact factor: 3.161

4.  Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.

Authors:  M Guembe; J Guinea; L J Marcos-Zambrano; A Fernández-Cruz; T Peláez; P Muñoz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

5.  Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole.

Authors:  André Moreira; Sónia Silva; Cláudia Botelho; Paula Sampaio; Célia Pais; Mariana Henriques
Journal:  Mycopathologia       Date:  2015-07-16       Impact factor: 2.574

6.  Rational selection of antifungal drugs to propose a new formulation strategy to control Candida biofilm formation on venous catheters.

Authors:  Paula Reginatto; Vanessa Zafanelli Bergamo; Simone Jacobus Berlitz; Irene Clemes Kulkamp Guerreiro; Saulo Fernandes de Andrade; Alexandre Meneghello Fuentefria
Journal:  Braz J Microbiol       Date:  2020-02-19       Impact factor: 2.476

Review 7.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

8.  Species distribution and virulence factors of Candida spp. isolated from the oral cavity of kidney transplant recipients in Brazil.

Authors:  Guilherme Maranhão Chaves; Mariana Guimarães Diniz; Walicyranison Plinio da Silva-Rocha; Luanda Bárbara Ferreira Canário de Souza; Libia Augusta Maciel Gondim; Maria Angela Fernandes Ferreira; Terezinha Inez Estivalet Svidzinski; Eveline Pipolo Milan
Journal:  Mycopathologia       Date:  2013-03-29       Impact factor: 2.574

9.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

10.  Candida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p.

Authors:  Célia Ferreira; Sónia Silva; Fábio Faria-Oliveira; Eva Pinho; Mariana Henriques; Cândida Lucas
Journal:  BMC Microbiol       Date:  2010-09-15       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.